Effect of Laser Puncture on Rheumatoid Arthritis Patients

December 31, 2020 updated by: A. Sedky, Cairo University
Studying the effect of laser puncture on rheumatoid arthritis patients

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • M. Sedky

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 75 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Meeting the criteria of ACR classification for rheumatoid arthritis
  • Meeting the criteria of EULAR classification for rheumatoid arthritis

Exclusion Criteria:

  • Having malignancy
  • Having connective tissue disease
  • Smokers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Procedure: Control
Exercise
Experimental: Laser Group
Device: Laser
Laser puncture and exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HAQ (Change)
Time Frame: Pre-intervention, 4 weeks
Health Assessment questionnaire
Pre-intervention, 4 weeks
RAQoL (Change)
Time Frame: Pre-intervention, 4 weeks
Rheumatoid Arthritis Quality of Life
Pre-intervention, 4 weeks
CRP (Change)
Time Frame: Pre-intervention, 4 weeks
Analysis of serum C-reactive protein
Pre-intervention, 4 weeks
IL-6 (Change)
Time Frame: Pre-intervention, 4 weeks
Plasma interleukin-6 inflammatory markers
Pre-intervention, 4 weeks
ATP (Change)
Time Frame: Pre-intervention, 4 weeks
Plasma ATP concentration anti-oxidant marker
Pre-intervention, 4 weeks
MDA (Change)
Time Frame: Pre-intervention, 4 weeks
plasma malondialdehyde oxidative marker
Pre-intervention, 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 25, 2020

Primary Completion (Anticipated)

January 20, 2021

Study Completion (Anticipated)

January 22, 2021

Study Registration Dates

First Submitted

December 16, 2020

First Submitted That Met QC Criteria

December 23, 2020

First Posted (Actual)

December 24, 2020

Study Record Updates

Last Update Posted (Actual)

January 5, 2021

Last Update Submitted That Met QC Criteria

December 31, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/010-2020

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on Laser

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe